Breaking News

QCTR Selects Medidata CTMS

SaaS-based system to help manage trials

QCTR Ltd., a specialty CRO, has selected Medidata Solutions CTMS, including its investigator site payment module, to manage the operations of its clinical studies. The company anticipates that Medidata SaaS-based CTMS will greatly reduce the time and effort needed to track key milestones and operational metrics across clinical studies and sites, from data entry as well as timely access to information and reports.

“Compared to other available systems, Medidata’s SaaS-based CTMS solution offered much greater value in terms of richness of features, speed of set-up, flexibility, ease-of-use and global accessibility without requiring extensive up-front investment,” said Susan McGoldrick, managing director, QCTR. “It’s evident that Medidata CTMS was developed with CRO-specific needs in mind.”

“Organizations such as QCTR clearly see Medidata CTMS as a new, better and cost-effective alternative to current CTMS choices: home-grown and spreadsheet-based tools that can’t keep up with today’s trial challenges or traditional CTMS software requiring substantial up-front investment and lengthy implementations,” said Tarek Sherif, chief executive officer, Medidata Solutions.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters